Efficacy and Safety of Lomitapide in Homozygous Familial Hypercholesterolaemia: A Systematic Review
Background: Homozygous familial hypercholesterolaemia (HoFH) patients have little or no low-density lipoprotein receptor (LDLR) function. HMG-CoA (3-hydroxy-3-methyl glutaryl coenzyme A) reductase inhibitors (statins) and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have limited...
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
IMR Press
2022-04-01
|
| سلاسل: | Reviews in Cardiovascular Medicine |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.imrpress.com/journal/RCM/23/5/10.31083/j.rcm2305151 |